Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Asano

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Rheumatology (Oxford, England)|July 13, 2024
A double-blind, placebo-controlled, randomized multiple dose phase 1b trial of a CDK4/6 inhibitor, TCK-276, in patients with active rheumatoid arthritisDaisuke Tasaki, Kazuoki Tsuruda, Shosho Sun, et al.
European Journal of Pharmacology|July 7, 2009
Inverse relationship between Sec14l3 mRNA/protein expression and allergic airway inflammationLihua Shan, Takao Kawakami, Satoshi Asano, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|February 22, 2023
Sagittal alignment cut-off values for predicting future fall-related fractures in community-dwelling osteoporotic womenRyoma Asahi, Yutaka Nakamura, Yoshinao Koike, et al.
Clinical Pharmacokinetics|April 19, 2023
Integrated Use of In Vitro and In Vivo Information for Comprehensive Prediction of Drug Interactions Due to Inhibition of Multiple CYP IsoenzymesShizuka Hozuki, Hideki Yoshioka, Satoshi Asano, et al.
Clinical Pharmacology and Therapeutics|May 27, 2025
Predicting OCT2/MATEs-Mediated Drug Interactions in Healthy Volunteers and Patients with Chronic Kidney Disease: Insights from Extended Clearance Concept, Endogenous Biomarkers, and In Vitro Inhibition Studies (Perspectives from the International Transporter Consortium)Satoshi Asano, Aleksandra Galetin, Yoshiko Tomita, et al.
Modern Rheumatology|August 27, 2022
Does locomotive syndrome severity predict future fragility fractures in community-dwelling women with osteoporosis?Ryoma Asahi, Yutaka Nakamura, Yoshinao Koike, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|May 7, 2015
Chronic Treatment with a Water-Soluble Extract from the Culture Medium of Ganoderma lucidum Mycelia Prevents Apoptosis and Necroptosis in Hypoxia/Ischemia-Induced Injury of Type 2 Diabetic Mouse BrainMeiyan Xuan, Mari Okazaki, Naohiro Iwata, et al.
Frontiers in Pharmacology|November 25, 2021
Generation of KS-133 as a Novel Bicyclic Peptide with a Potent and Selective VIPR2 Antagonist Activity that Counteracts Cognitive Decline in a Mouse Model of Psychiatric DisordersKotaro Sakamoto, Lu Chen, Tatsunori Miyaoka, et al.
The EMBO Journal|May 28, 2005
Concerted mechanism of Swe1/Wee1 regulation by multiple kinases in budding yeastSatoshi Asano, Jung-Eun Park, Krisada Sakchaisri, et al.
Frontiers in Oncology|October 14, 2022
Vasoactive intestinal peptide-VIPR2 signaling regulates tumor cell migrationSatoshi Asano, Misa Yamasaka, Kairi Ozasa, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Rheumatology (Oxford, England)|July 13, 2024
A double-blind, placebo-controlled, randomized multiple dose phase 1b trial of a CDK4/6 inhibitor, TCK-276, in patients with active rheumatoid arthritisDaisuke Tasaki, Kazuoki Tsuruda, Shosho Sun, et al.
European Journal of Pharmacology|July 7, 2009
Inverse relationship between Sec14l3 mRNA/protein expression and allergic airway inflammationLihua Shan, Takao Kawakami, Satoshi Asano, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|February 22, 2023
Sagittal alignment cut-off values for predicting future fall-related fractures in community-dwelling osteoporotic womenRyoma Asahi, Yutaka Nakamura, Yoshinao Koike, et al.
Clinical Pharmacokinetics|April 19, 2023
Integrated Use of In Vitro and In Vivo Information for Comprehensive Prediction of Drug Interactions Due to Inhibition of Multiple CYP IsoenzymesShizuka Hozuki, Hideki Yoshioka, Satoshi Asano, et al.
Clinical Pharmacology and Therapeutics|May 27, 2025
Predicting OCT2/MATEs-Mediated Drug Interactions in Healthy Volunteers and Patients with Chronic Kidney Disease: Insights from Extended Clearance Concept, Endogenous Biomarkers, and In Vitro Inhibition Studies (Perspectives from the International Transporter Consortium)Satoshi Asano, Aleksandra Galetin, Yoshiko Tomita, et al.
Modern Rheumatology|August 27, 2022
Does locomotive syndrome severity predict future fragility fractures in community-dwelling women with osteoporosis?Ryoma Asahi, Yutaka Nakamura, Yoshinao Koike, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|May 7, 2015
Chronic Treatment with a Water-Soluble Extract from the Culture Medium of Ganoderma lucidum Mycelia Prevents Apoptosis and Necroptosis in Hypoxia/Ischemia-Induced Injury of Type 2 Diabetic Mouse BrainMeiyan Xuan, Mari Okazaki, Naohiro Iwata, et al.
Frontiers in Pharmacology|November 25, 2021
Generation of KS-133 as a Novel Bicyclic Peptide with a Potent and Selective VIPR2 Antagonist Activity that Counteracts Cognitive Decline in a Mouse Model of Psychiatric DisordersKotaro Sakamoto, Lu Chen, Tatsunori Miyaoka, et al.
The EMBO Journal|May 28, 2005
Concerted mechanism of Swe1/Wee1 regulation by multiple kinases in budding yeastSatoshi Asano, Jung-Eun Park, Krisada Sakchaisri, et al.
Frontiers in Oncology|October 14, 2022
Vasoactive intestinal peptide-VIPR2 signaling regulates tumor cell migrationSatoshi Asano, Misa Yamasaka, Kairi Ozasa, et al.
Pageof 10